Nexentis Technologies Inc. (NXTS) Stock
Nexentis Technologies stock price chart
NXTS stock quote & key statistics
Nexentis Technologies annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0 | -$4.0M | — |
| FY2024 | $210,000 | -$5.2M | -$243.44 |
| FY2023 | $263,445 | -$6.5M | -$4032.77 |
| FY2022 | $394,004 | -$5.7M | -$2894.92 |
| FY2021 | $438,141 | -$4.8M | -$3447.63 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Nexentis Technologies Inc.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Nexentis Technologies stock FAQ
What is the Nexentis Technologies stock ticker symbol?
Nexentis Technologies Inc. trades on the NASDAQ under the ticker symbol NXTS.
What sector and industry is Nexentis Technologies in?
Nexentis Technologies Inc. is classified in the Basic Materials sector, Agricultural Inputs industry.
How many employees does Nexentis Technologies have?
Nexentis Technologies Inc. has about 7 full-time employees.
What were Nexentis Technologies's revenue and earnings last fiscal year?
Nexentis Technologies reported revenue of $0 and net income of -$4.0M in fiscal 2025. Revenue declined 100.0% from the prior year.
When did Nexentis Technologies go public?
Nexentis Technologies stock began trading on October 18, 2017.